Skip to main content
Clinical Trials/IRCT201105166500N1
IRCT201105166500N1
Completed
Phase 2

Comparison of two different drug regimen containing tacrolimus and cyclosporine on graft survival and the survival rate of patients as immunosuppressive regimens in kidney transplantation

Kermanshah University of Medical Scienes and Health Services0 sites200 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
survival of transplanted kidney.
Sponsor
Kermanshah University of Medical Scienes and Health Services
Enrollment
200
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kermanshah University of Medical Scienes and Health Services

Eligibility Criteria

Inclusion Criteria

  • all patients with chronic renal failure aged 16 to 65 who were undergoing kidney transplantation and immunosuppressive therapy for graft. Exclusion criteria: patients with other diseases such as cancer; intraoperative surgical complications in renal transplantation in grafts; graft loss due to vascular complications created from the graft surgery; death (due to other causes than rejection); switching immunosuppressive treatment regimen for any reason.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials